Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New Caution Urged Over Sole Oral MS Drug On the Market
New Caution Urged Over Sole Oral MS Drug On the Market
New Caution Urged Over Sole Oral MS Drug On the Market
Submitted by
admin
on May 15, 2012 - 10:30am
Source:
WSJ Online
News Tags:
MS
multiple sclerosis
Novartis
Gilenya
FDA
Headline:
New Caution Urged Over Sole Oral MS Drug On the Market
Do Not Allow Advertisers to Use My Personal information
